373 related articles for article (PubMed ID: 27332881)
1. Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment.
Zeng C; Plastaras JP; James P; Tochner ZA; Hill-Kayser CE; Hahn SM; Both S
Acta Oncol; 2016; 55(9-10):1132-1138. PubMed ID: 27332881
[TBL] [Abstract][Full Text] [Related]
2. Proton pencil beam scanning for mediastinal lymphoma: the impact of interplay between target motion and beam scanning.
Zeng C; Plastaras JP; Tochner ZA; White BM; Hill-Kayser CE; Hahn SM; Both S
Phys Med Biol; 2015 Apr; 60(7):3013-29. PubMed ID: 25789418
[TBL] [Abstract][Full Text] [Related]
3. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
[TBL] [Abstract][Full Text] [Related]
4. Technical challenges in the treatment of mediastinal lymphomas by proton pencil beam scanning and deep inspiration breath-hold.
Righetto R; Fracchiolla F; Widesott L; Lorentini S; Dionisi F; Rombi B; Scartoni D; Vennarini S; Schwarz M; Farace P
Radiother Oncol; 2022 Apr; 169():43-50. PubMed ID: 35189153
[TBL] [Abstract][Full Text] [Related]
5. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435
[TBL] [Abstract][Full Text] [Related]
6. Beam-specific planning target volumes incorporating 4D CT for pencil beam scanning proton therapy of thoracic tumors.
Lin L; Kang M; Huang S; Mayer R; Thomas A; Solberg TD; McDonough JE; Simone CB
J Appl Clin Med Phys; 2015 Nov; 16(6):5678. PubMed ID: 26699580
[TBL] [Abstract][Full Text] [Related]
7. Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons.
Kang Y; Shen J; Liu W; Taylor PA; Mehrens HS; Ding X; Hu Y; Tryggestad E; Keole SR; Schild SE; Wong WW; Fatyga M; Bues M
Radiat Oncol; 2019 Jun; 14(1):108. PubMed ID: 31208439
[TBL] [Abstract][Full Text] [Related]
8. Clinical implementation of intensity modulated proton therapy for thoracic malignancies.
Chang JY; Li H; Zhu XR; Liao Z; Zhao L; Liu A; Li Y; Sahoo N; Poenisch F; Gomez DR; Wu R; Gillin M; Zhang X
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):809-18. PubMed ID: 25260491
[TBL] [Abstract][Full Text] [Related]
9. Strategies for Motion Robust Proton Therapy With Pencil Beam Scanning for Esophageal Cancer.
Møller DS; Poulsen PR; Hagner A; Dufour M; Nordsmark M; Nyeng TB; Mortensen HR; Lutz CM; Hoffmann L
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):539-548. PubMed ID: 33974885
[TBL] [Abstract][Full Text] [Related]
10. Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.
Lee E; Zeng J; Miyaoka RS; Saini J; Kinahan PE; Sandison GA; Wong T; Vesselle HJ; Rengan R; Bowen SR
Med Phys; 2017 Jul; 44(7):3418-3429. PubMed ID: 28453861
[TBL] [Abstract][Full Text] [Related]
11. Comparison of prostate proton treatment planning technique, interfraction robustness, and analysis of single-field treatment feasibility.
Kirk ML; Tang S; Zhai H; Vapiwala N; Deville C; James P; Bekelman JE; Christodouleas JP; Tochner Z; Both S
Pract Radiat Oncol; 2015; 5(2):99-105. PubMed ID: 25413411
[TBL] [Abstract][Full Text] [Related]
12. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
13. Motion effects in proton treatments of hepatocellular carcinoma-4D robustly optimised pencil beam scanning plans versus double scattering plans.
Pfeiler T; Ahmad Khalil D; Ayadi M; Bäumer C; Blanck O; Chan M; Engwall E; Geismar D; Peters S; Plaude S; Spaan B; Timmermann B; Wulff J
Phys Med Biol; 2018 Nov; 63(23):235006. PubMed ID: 30468685
[TBL] [Abstract][Full Text] [Related]
14. Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
Ntentas G; Dedeckova K; Andrlik M; Aznar MC; George B; Kubeš J; Darby SC; Cutter DJ
Pract Radiat Oncol; 2019 May; 9(3):179-187. PubMed ID: 30708133
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
[TBL] [Abstract][Full Text] [Related]
16. Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy.
Edvardsson A; Kügele M; Alkner S; Enmark M; Nilsson J; Kristensen I; Kjellén E; Engelholm S; Ceberg S
Acta Oncol; 2019 Jan; 58(1):95-104. PubMed ID: 30280626
[TBL] [Abstract][Full Text] [Related]
17. Efficient Interplay Effect Mitigation for Proton Pencil Beam Scanning by Spot-Adapted Layered Repainting Evenly Spread out Over the Full Breathing Cycle.
Poulsen PR; Eley J; Langner U; Simone CB; Langen K
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):226-234. PubMed ID: 29254775
[TBL] [Abstract][Full Text] [Related]
18. Comparative photon and proton dosimetry for patients with mediastinal lymphoma in the era of Monte Carlo treatment planning and variable relative biological effectiveness.
Tseng YD; Maes SM; Kicska G; Sponsellor P; Traneus E; Wong T; Stewart RD; Saini J
Radiat Oncol; 2019 Dec; 14(1):243. PubMed ID: 31888769
[TBL] [Abstract][Full Text] [Related]
19. Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy.
Horn S; Fournier-Bidoz N; Pernin V; Peurien D; Vaillant M; Dendale R; Fourquet A; Kirova YM
Cancer Radiother; 2016 Apr; 20(2):98-103. PubMed ID: 26992750
[TBL] [Abstract][Full Text] [Related]
20. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]